HDAC3 and prostate cancer: The varying levels of IP-10 among prostate cancer cell lines was explained by enhanced recruitment of the NCoR-HDAC3 corepressor complex to the AP-1 site of the IP-10 promoter in PC-3 cells compared with RWPE1 and LNCaP cells, which was reversed by blocking CK2 activity.